Clustering data with hclust algorithm for NIH WCMC Pilot & Feasibility Project: ?Metabolomics of Neonatal Pulmonary Hypertension? in human (Study ST000255)

ESI negative ion mode (Analysis AN000403)
MetaboliteStructureF1F2
9-HODEME7016300.631.37
PGE1ME7016110.601.40
13-HODEME7016290.611.39
9-HETEME7016350.611.39
9-KODEME7016540.531.47
13-HOTEME7016310.461.54
9-HOTEME7016320.461.54
12(13)-Ep-9-KODEME7016480.501.50
13-KODEME7016530.491.51
12-HETEME7016340.231.77
14-HDoHEME7016430.181.82
12-HEPEME7016390.311.69
19(20)-EpDPEME7016520.331.57
8(9)-EpETrEME7016510.401.62
6-keto PGF1aME7016091.080.92
9_12_13-TriHOMEME7016170.891.11
11_12-DiHETrEME7016230.891.11
15-HEPEME7016380.891.11
14_15-DiHETrEME7016220.881.12
17_18-DiHETEME7016260.871.13
5_6-DiHETrEME7016250.941.06
PGD2ME7016140.951.06
PGF2aME7016150.911.08
8_9-DiHETrEME7016240.921.08
9_10-EpOME7016450.921.09
14(15)-EpETrEME7016500.851.18
19_20-DiHDoPEME7016280.841.16
9-HEPEME7016400.841.17
9(10)-EpOMEME7016470.821.18
PGE2ME7016120.801.20
8-HETEME7016360.811.19
9_10-DiHODEME7016210.801.19
15_16-DiHODEME7016200.691.28
15(16)-EpODEME7016490.671.29
9_10-DiHOMEME7016190.781.22
12(13)-EpOMEME7016460.761.24
TXB2ME7016100.771.23
11-HETEME7016160.771.23
15-HETEME7016330.771.23
15-Keto PGE2ME7016130.761.29
5-HEPEME7016410.731.29
12_13-DiHOME (Area Ratio%)ME7016180.721.28
5-HETEME7016370.721.28
4-HDoHEME7016440.751.25
14_15-DiHETEME7016270.731.25
17-HDoHEME7016420.741.26

Factors:

F1Treatment:no PH (no pulmonary hypertension)
F2Treatment:PH (pulmonary hypertension)
Data matrix
  logo